November 15, 2024. VOX. TAG President and CEO Dr. David Acheson provides insights on the current state of FDA and the impact the Trump nomination of Robert F. Kennedy Jr as Health and Human Services (HHS) secretary could have. [Read the article]
we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.
November 15, 2024. VOX. TAG President and CEO Dr. David Acheson provides insights on the current state of FDA and the impact the Trump nomination of Robert F. Kennedy Jr as Health and Human Services (HHS) secretary could have. [Read the article]
© 2026 The Acheson Group. All rights reserved